Search Results
Search results for "Tao Che"
Results found for "Tao Che"
- Gunnar Schulte: Frizzled Receptors and the GPCR Identity Question | Dr. GPCR Ecosystem
Every chemical modification so far has converted it into an antagonist rather than a stronger agonist His supervisor, Bertil Fredholm, asked a single question: had he checked whether those inhibitors were describes the experience as formative, and the lesson as one that has quietly shaped his approach to chemical Pharmacology, British Journal of Pharmacology, Pharmacological Reviews, and The Journal of Biological Chemistry
- Tuning GPCR System Sensitivity: Revealing True Drug Activity Through Functional Volume Control | Dr. GPCR Ecosystem
Kenakin trained in chemistry and pharmacology at the University of Alberta and completed postdoctoral
- Terry Hébert | Dr. GPCR Ecosystem
GPCR Summit 2020 announcement 01:49 Check-in with Dr.
- Chris Langmead | Dr. GPCR Ecosystem
Chris serves on the editorial boards of the British Journal of Pharmacology, ACS Chemical Neuroscience
- Dr. GPCR Team | Dr. GPCR Ecosystem
Her work focused on chemokine receptors, members of the GPCR family that control cell movement in the As a young researcher fascinated by chemokine receptors, molecular pharmacology, drug discovery, and Further down the track, he aims to apply this knowledge to develop novel chemical treatments for neuronal
- Exploring Career Paths in GPCR Research with Dr. Jacek Mokrosiński | Dr. GPCR Ecosystem
He works in a multidisciplinary Chemical Biology team based at the recently established US R&D hub in Always check for accuracy. passion for advancing science and improving patient outcomes, and their early interests in science and chemistry
- Bryan Roth: Inside the DARPA Bet on a Non-Psychedelic Psychedelic | Dr. GPCR Ecosystem
psychedelic for depression — and why the real bottleneck in GPCR drug discovery is the biology, not the chemistry discovery against GPCRs actually requires, why most hypotheses still fail at the indication rather than the chemistry Key Insights from the Conversation The bottleneck in GPCR drug discovery is the indication, not the chemistry Roth is direct about this: with sufficient medicinal chemistry resources and modern assays, you can make Six weeks in, structures are turning over and chemistry is iterating.
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour Always check for accuracy.
- Dr. Hannes Schihada | Dr. GPCR Ecosystem
By the end of 2021, I moved back to Germany and joined the pharmaceutical chemistry group of Peter Kolb
- Dr. Bianca Plouffe | Dr. GPCR Ecosystem
focused on understanding the role of compartmentalized Gq signaling by the cytomegalovirus-encoded chemokine
- Jennifer Pluznick: Olfactory Receptors in the Kidney and the Gut-Microbe Signal | Dr. GPCR Ecosystem
explores what changes when olfactory receptors are treated not as smell receptors but as general-purpose chemosensors Scientific Themes of the Conversation Olfactory receptors as general-purpose chemosensors outside the Reframing olfactory receptors as chemosensors. Pluznick argues they are better understood as chemical sensors that happen to dominate the nose. Her research is focused on the role of chemosensory GPCRs in regulating renal and cardiovascular function
- Receptor Signaling Bias: A Valuable and Accessible Property of New Drug Candidates | Dr. GPCR Ecosystem
Kenakin trained in chemistry and pharmacology at the University of Alberta and completed postdoctoral
- Dr. Claudia Stäubert | Dr. GPCR Ecosystem
Always check for accuracy.
- Pfleger: NanoBRET, Receptor Complexes, and the Translation of GPCR Pharmacology | Dr. GPCR Ecosystem
platforms have been applied across arrestin biology, receptor complex pharmacology, and the angiotensin and chemokine interactions, with a focus on arrestin signaling, receptor complex pharmacology, and the angiotensin and chemokine
- Chloe Hicks | Dr. GPCR Ecosystem
and has contributed to multiple projects exploring the underlying mechanisms of biased signaling at chemokine which involves identifying the non-canonical signaling effectors involved in the activation of Atypical Chemokine
- Dr. Timo De Groof | Dr. GPCR Ecosystem
From 2015 to 2019, he completed his Ph.D. in the Medicinal Chemistry group at VU University Amsterdam targeting viral G protein-coupled receptors with a special focus on the human cytomegalovirus-encoded chemokine
- Fiona Marshall: Three Decades Inside GPCR Drug Discovery | Dr. GPCR Ecosystem
The shift came through the tumor microenvironment — immune cells, chemokine receptors, adenosine signaling
- Scaling GLP 1 Receptor Tools Through Academia Industry Collaboration | Dr. GPCR Ecosystem
Together, we discuss how gpcr drug discovery advances when chemists, biologists, and industry partners She earned her PhD in medicinal chemistry from the University of Bari in 2018, including research training Her work centers on GPCR modulators, synthetic chemistry, and enabling robust biological assays through high-quality chemical tools. Trained as a chemist, he studied at the University of Erlangen–Nuremberg and completed his PhD at LMU
- Beatriz Blanco-Redondo: Adhesion GPCR Discovery in Drosophila | Dr. GPCR Ecosystem
And then at the end, you can discover what a receptor that was there in the fly - nobody ever checked
- Self-Learning, Collaboration, and Delegation in Science with Dr. Badr Sokrat | Dr. GPCR Ecosystem
Always check for accuracy. Yamina’s Podcast Journey and Career Advice Yamina discussed how her podcast on chemokine ligands led Yamina shared her experiences at Rockefeller, where she studied chemical receptors.
- Dr. Bruno Giros | Dr. GPCR Ecosystem
Duke University in North Carolina, working with Marc Caron and Robert Lefkowitz (2012 Nobel Prize in Chemistry
- Brian Bender: Computational Probes for Orphan GPCR | Dr. GPCR Ecosystem
Bender uses virtual docking to find chemical probes for orphan GPCRs - receptors biology can't study superfamily contains hundreds of receptors that cannot be experimentally studied because no usable chemical paramagnetic resonance spectroscopy - and applies large-scale virtual docking to identify candidate chemical of GPCRs from sparse and low-resolution experimental data Virtual docking as a strategy for pan-GPCR chemical one Without a usable chemical probe, a GPCR cannot be studied pharmacologically in a cell-based setting
- Silvio Gutkind: When GPCRs Drive Cancer | Dr. GPCR Ecosystem
moved from a side project nobody believed in to a recognized driver class in oncology, and explains why chemokine include GαQ-driven uveal melanoma, GαS mutations across pancreatic, colon, and appendix cancers, and chemokine pathway Non-canonical GαQ signaling through TRIO, Rho, YAP, and the druggable FAK node CXCR3 and the chemokine CXCL9, CXCL10, and CXCL11 are among the most robust predictive signatures for checkpoint inhibitor response The cancer genomics result that reframed GPCRs as drivers 16:45 Why CXCR3 may decide who responds to checkpoint
- Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour Always check for accuracy.
- Eleonora Comeo: Fluorescent Ligands and the Pharmacology of Adenosine Receptors | Dr. GPCR Ecosystem
For Comeo, who entered GPCR research without any background in the field and built her PhD around chemistry A trained medicinal chemist and pharmacist, her research focuses on the design and synthesis of fluorescent ligands for adenosine A1 and A2A receptors, with the goal of developing chemical tools capable of interrogating SCIENTIFIC THEMES OF THE CONVERSATION Fluorescent ligands as pharmacological tools - how synthetic chemistry About this episode Eleonora Comeo is a doctoral candidate in Medicinal Chemistry and Drug Discovery in
- Dr. David Sykes | Dr. GPCR Ecosystem
fluorescence-based kinetic binding assays specifically designed to assess the kinetics of unlabelled compounds (and chemical
- Dr. Josh Pottel | Dr. GPCR Ecosystem
(MFI): a reliable, self-sustaining computational chemistry service provider, developing its own software I am now combining my training as a chemist and as an entrepreneur to grow a sustainable service and
- Dr. Richard Premont | Dr. GPCR Ecosystem
Premont obtained his B.S. in Biology and Chemistry at the California Institute of Technology in 1985,
- A Brief History of allosteric modulation with Dr. Arthur Christopoulos | Dr. GPCR Ecosystem
modulation and biased agonism, and incorporates computational and mathematical modelling, structural and chemical biology, molecular and cellular pharmacology, medicinal chemistry, and preclinical models of behaviour radioligand binding assays to cell-based functional assays, and the influence of Terry Kenakin and chemical They also discussed their own research on chemokine receptors and the importance of understanding the
- Dr. Peter Robert Banks | Dr. GPCR Ecosystem
Prior to experiences at PerkinElmer and BioTek, Banks was an Assistant Professor in Analytical Chemistry




























